Tuberc Respir Dis.  2014 Dec;77(6):271-273. 10.4046/trd.2014.77.6.271.

Systemic Nocardiosis Mimicking Disease Flare-up after Discontinuation of Gefitinib in a Patient with EGFR-Mutant Lung Cancer

• Choi M
• Lee Y
• Hwang SH
• Lee JS

• KMID: 1842996
• DOI: http://doi.org/10.4046/trd.2014.77.6.271

Abstract

Disease flare-up after discontinuing epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) has been considered as a critical issue in lung cancer patients who have experienced radiologic progression after showing initial durable response. This is a case of systemic nocardiosis that occurred after chronic steroid use for radionecrosis from stereotactic radiosurgery. It was initially thought as a disease flare-up after stopping EGFR-TKI.

Keyword

EGFR Tyrosine Kinase Inhibitor 324674; Nocardia Infections; Carcinoma, Non-Small-Cell Lung; Radiosurgery

MeSH Terms

Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms*
Nocardia Infections*
Protein-Tyrosine Kinases
Radiosurgery
Receptor, Epidermal Growth Factor
Protein-Tyrosine Kinases
Receptor, Epidermal Growth Factor

Figure

• 

  Figure 1 Serial radiologic evaluation including chest X-ray scans (A) and brain magnetic resonance imaging (B, C). TMP-SMX: trimethoprim-sulfamethoxazole.

Reference

1. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350:2129–2139.

2. Chaft JE, Oxnard GR, Sima CS, Kris MG, Miller VA, Riely GJ. Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design. Clin Cancer Res. 2011; 17:6298–6303.

3. Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003; 41:4497–4501.

4. Ambrosioni J, Lew D, Garbino J. Nocardiosis: updated clinical review and experience at a tertiary center. Infection. 2010; 38:89–97.

5. Kano H, Kondziolka D, Zorro O, Lobato-Polo J, Flickinger JC, Lunsford LD. The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg. 2009; 111:825–831.

6. Petrovich Z, Yu C, Giannotta SL, O'Day S, Apuzzo ML. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg. 2002; 97:5 Suppl. 499–506.